As the name entails, paraneoplastic encephalomyelitis is associated with the presence of cancer, especially prevalent in small cell lung cancer (SCLC), in addition to breast cancer, testicular cancer, gynecologic cancers, and Hodgkinâ€™s lymphoma.

Immune checkpoint inhibitors are believed to unleash paraneoplastic neurological syndromes as well, more frequently with anti-PD1 agents eg. pembrolizumab, nivolumab, and cemiplimab.